Education
About Us
Working with TipRanks
Follow Us
Integrated BioPharma (INBP)
:INBP
INBP Stock Chart & Stats
$0.30
$0.02(5.88%)
At close: 4:00 PM EST
$0.30
$0.02(5.88%)
Day’s Range― - ―
52-Week Range$0.22 - $0.42
Previous CloseN/A
Volume200.00
Average Volume (3M)8.84K
Market Cap
$9.33M
Enterprise Value$8.33M
Total Cash (Recent Filing)$3.62M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)11.7
Beta0.25
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding31,059,610
10 Day Avg. Volume3,700
30 Day Avg. Volume8,836
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.53
Price to Sales (P/S)0.20
P/FCF Ratio5.77
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit1.50
Enterprise Value/Ebitda2.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Integrated BioPharma News
INBP FAQ
What was Integrated BioPharma’s price range in the past 12 months?
Integrated BioPharma lowest stock price was $0.22 and its highest was $0.42 in the past 12 months.
What is Integrated BioPharma’s market cap?
Integrated BioPharma’s market cap is $9.33M.
When is Integrated BioPharma’s upcoming earnings report date?
Integrated BioPharma’s upcoming earnings report date is Nov 06, 2025 which is in 5 days.
How were Integrated BioPharma’s earnings last quarter?
Integrated BioPharma released its earnings results on Sep 23, 2025. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is Integrated BioPharma overvalued?
According to Wall Street analysts Integrated BioPharma’s price is currently Overvalued.
Does Integrated BioPharma pay dividends?
Integrated BioPharma does not currently pay dividends.
What is Integrated BioPharma’s EPS estimate?
Integrated BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated BioPharma have?
Integrated BioPharma has 31,059,610 shares outstanding.
What happened to Integrated BioPharma’s price movement after its last earnings report?
Integrated BioPharma reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 22.222%.
Which hedge fund is a major shareholder of Integrated BioPharma?
Currently, no hedge funds are holding shares in INBP
Company Description
Integrated BioPharma
Integrated BioPharma (INBP) is a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative healthcare products. The company operates primarily in the pharmaceutical and nutraceutical sectors, offering a diverse portfolio of prescription and over-the-counter medications, dietary supplements, and wellness products. INBP is committed to advancing health through research and development, with a strong emphasis on delivering high-quality, effective solutions for various health conditions.
Technical Analysis
Natural Alternatives International
―
Sow Good
―
FitLife Brands
―
Bon Natural Life
―
Healthy Choice Wellness Corp. Class A
―
Ownership Overview
Options Prices
Currently, No data available
---